
CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs
Santa Cruz, USA / Basel, CH
Joined April 2009
- Tweets30.2K
- Following5.2K
- Followers18K
- Likes11.1K
Off-Label Efgartigimod Helps Young Woman with Severe, Treatment-Resistant LEMS Regain Mobility and Independence - For More Information Visit tinyurl.com/33x6e3eu #Lambert_Eaton #LEMS #Rare_Diseases
2
101
GSK’s Velzatinib Receives Japan’s Orphan Drug Designation for Gastrointestinal Stromal Tumor Treatment (GIST) - For More Information Visit tinyurl.com/hs3hj826 @GSK @GSKUS #Rare_Diseases #GIST #Orphan_Drugs #Gastrointestinal_Stromal_Tumor #Cancer_research
83
Livsayis™ (cemdisiran), First FDA-Approved siRNA Therapy for Generalized Myasthenia Gravis Offering Convenient Quarterly Subcutaneous Dosing - For More Information Visit tinyurl.com/dw8bjea5 @Regeneron #FDA #gMG #Myasthenia_Gravis #Rare_Diseases #Orphan_Drugs
76
Inhibrx Reports 62.7% Overall Response Rate for Ozekibart Combination Therapy in Relapsed or Refractory Ewing Sarcoma - For More Information Visit tinyurl.com/yc5n3tj2 @inhibrx #Ewing_Sarcoma #Rare_Diseases #Orphan_Drugs #cancer_treatment
105
Karyopharm Announces FDA Acceptance of sNDA for XPOVIO® (selinexor) Plus Ruxolitinib for the Treatment of Patients with Myelofibrosis - For More Information Visit tinyurl.com/4y5d6cde @Karyopharm #Myelofibrosis #FDA #XPOVIO #Rare_Diseases #Orphan_Drugs
110
European Commission Approves Sobi’s Tryngolza as First RNA-Targeted Therapy for Severe Hypertriglyceridemia in the EU - For More Information Visit tinyurl.com/29z5vb9z #Sobi #Rare_Diseases #Orphan_Drugs #Severe_Hypertriglyceridemia #sHTG
125
Rare Cancers Publishes Case Report Detailing Eight-Year Response to Relacorilant Plus Nab-Paclitaxel in Metastatic Vulvar Cancer - For More Information Visit For More Information Visit tinyurl.com/yc742vkp #ESMO #Vulvar_Cancer #Corcept_Therapeutics #Rare_Cancers
116
Neurizon Announces First Participant Completes 36-Week Phase of HEALEY ALS Trial and Transitions to Active Treatment Extension - For More Information Visit tinyurl.com/47j4evmm @Neurizon_ltd #Rare_Diseases #ALS #Orphan_Drugs #Amyotrophic_Lateral_Sclerosis
126
Lexeo Therapeutics Reports Positive Interim Phase I/II Data for LX2020, Demonstrating Reduced Arrhythmia Burden in PKP2-ACM Patients - For More Information Visit tinyurl.com/5faf6v69 #Lexeo_Therapeutics #ACM #Arrhythmogenic_Cardiomyopathy #Rare_Diseases #Orphan_Drugs
97
Roche’s Gazyva/Gazyvaro Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy - For More Information Visit tinyurl.com/4n77jcsh @Roche #Rare_Diseases #Orphan_Drugs #pMN #FDA #Primary_Membranous_Nephropathy #kidney_Diseases #Gazyva
Novartis Receives Positive CHMP Opinion for Cosentyx® in Adolescents aged 12+ with Hidradenitis Suppurativa (HS) - For More Information Visit tinyurl.com/4p5twcjc @Novartis #CHMP #Rare_Diseases #Orphan_Drugs #Cosentyx #Hidradenitis_Suppurativa #Drug_Research
1
162
CHMP Recommends EU Approval of Roche’s Gazyva/Gazyvaro for Systemic Lupus Erythematosus (SLE) - For More Information Visit tinyurl.com/mr2b4zva @Roche #SLE #Systemic_Lupus_Erythematosus #CHMP #Rare_Diseases #Orphan_Drugs #Gazyva
Novo Submits Etavopivat, an Investigational Once-Daily Therapy for Adolescents and Adults Living with Sickle Cell Disease, to The FDA and EMA For Approval - For More Information Visit tinyurl.com/m64a6dcd @novonordiskus #FDA #EMA #Sickle_Cell_Disease #Rare_Diseases
3
179
Ionis Reports New Two-Year Data Showing Sustained 95% Reduction in Hereditary Angioedema Attacks with DAWNZERA at ACAAI 2026 Annual Meeting - For More Information Visit tinyurl.com/mtb4uesb @ionispharma #HAE #Hereditary_Angioedema #Rare_Diseases #Orphan_Drugs
Bexsero ( 4CMenB ) receives positive CHMP opinion for one-dose Meningitis B booster for 10+ year olds - For More Information Visit tinyurl.com/3edvvdrv @gskca #Meningitis_B #Meningitis #Rare_Diseases #CHMP
134
Can-Fite's Piclidenoson Shows Up to 80% Kidney Disease Marker Improvement in Lowe Syndrome Preclinical Study Published in Nature Portfolio Journal - For More Information Visit tinyurl.com/2yxk8f2c @CanFitePharma #Lowe_Syndrome #Rare_Diseases #Orphan_Drugs
119
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ACR Convergence 2026 - For More Information Visit tinyurl.com/dkxpfw7m @Palleon_Pharma #Orphan_Drugs #pMN #Rare_Diseases #Primary_Membranous_Nephropathy
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® in Squamous Cell Anal Carcinoma - For More Information Visit tinyurl.com/mr49skkj @Oncolytics #SCAC #Anal_Cancer #Rare_Diseases #Orphan_Drugs
99
Enhertu® Supplemental New Drug Application Submitted in Japan for Patients with HER2 Expressing Advanced or Recurrent Uterine Carcinosarcoma - For More Information Visit tinyurl.com/ku4taepr #UCS #Rare_Diseases @DaiichiSankyo #Uterine_Carcinosarcoma
99
Novartis Reports Sustained Long-Term Efficacy and Safety of Ianalumab for Sjögren’s Disease Based on NEPTUNUS Extension Study Results - For More Information Visit tinyurl.com/8fnvwbbs @Novartis #Sjögren_Syndrome #Ianalumab #Rare_Diseases #Orphan_Drugs


















